カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界のサイトメガロウイルス（CMV）治療薬市場2022年～2026年

■ 英語タイトル：Global Cytomegalovirus (CMV) Therapeutics Market 2022-2026

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR73256-22）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR73256-22
■ 発行日：2022年4月19日
■ 調査対象地域：北米、ヨーロッパ、アジア、その他地域
■ 産業分野：医薬品
■ ページ数：約120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,000 ⇒換算￥456,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のサイトメガロウイルス（CMV）治療薬市場2022年～2026年]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

テクナビオ社は、世界のサイトメガロウイルス（CMV）治療薬市場規模が2022年から2026年まで年平均5.44％成長し、332.21百万ドルに達すると予測しています。本調査レポートでは、サイトメガロウイルス（CMV）治療薬の世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、投与経路別（経口、非経口、その他）分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析など、以下の内容を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のサイトメガロウイルス（CMV）治療薬市場規模：投与経路別（経口、非経口、その他）
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析

Global Cytomegalovirus (CMV) Therapeutics Market 2022-2026

Technavio has been monitoring the cytomegalovirus (CMV) therapeutics market and it is poised to grow by $ 332.21 mn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. Our report on the cytomegalovirus (CMV) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing risk factors for CMV, the recurring nature of the disease, and the high prevalence of congenital CMV.

The cytomegalovirus (CMV) therapeutics market analysis includes the route of administration segment and geographic landscape.
Technavio’s cytomegalovirus (CMV) therapeutics market is segmented as below:

By Route of Administration
• Oral
• Parenteral
• Others

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the reformulation of drugs as one of the prime reasons driving the cytomegalovirus (CMV) therapeutics
market growth during the next few years. Also, the advent of vaccines and newborn screening will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the cytomegalovirus (CMV) therapeutics market covers the following areas:
• Cytomegalovirus (CMV) therapeutics market sizing
• Cytomegalovirus (CMV) therapeutics market forecast
• Cytomegalovirus (CMV) therapeutics market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cytomegalovirus (CMV) therapeutics market vendors that include Astellas Pharma Inc., AstraZeneca Plc, Bausch Health Companies Inc., Chimerix Inc., Clinigen Group Plc, Exela Pharma Sciences LLC, F. Hoffmann La Roche Ltd., Fortress Biotech Inc., Fresenius SE, and Co. KGaA, Genentech Inc., Gilead Sciences Inc., Merck and Co. Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., UbiVac, and VBI Vaccines Inc. Also, the cytomegalovirus (CMV) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/cytomegalovirus-cmv-therapeutics-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Route of Administration
o 5.1 Market segments
o Exhibit 24: Chart on Route of Administration – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Route of Administration – Market share 2021-2026 (%)
o 5.2 Comparison by Route of Administration
o Exhibit 26: Chart on Comparison by Route of Administration
o Exhibit 27: Data Table on Comparison by Route of Administration
o 5.3 Oral – Market size and forecast 2021-2026
o Exhibit 28: Chart on Oral – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Oral – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Oral – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Oral – Year-over-year growth 2021-2026 (%)
o 5.4 Parenteral – Market size and forecast 2021-2026
o Exhibit 32: Chart on Parenteral – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Parenteral – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Parenteral – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Parenteral – Year-over-year growth 2021-2026 (%)
o 5.5 Others – Market size and forecast 2021-2026
o Exhibit 36: Chart on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others – Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Route of Administration
o Exhibit 40: Market opportunity by Route of Administration ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Denmark – Market size and forecast 2021-2026
o Exhibit 66: Chart on Denmark – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Denmark – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Denmark – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Denmark – Year-over-year growth 2021-2026 (%)
o 7.9 China – Market size and forecast 2021-2026
o Exhibit 70: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.10 Canada – Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.11 India – Market size and forecast 2021-2026
o Exhibit 78: Chart on India – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on India – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on India – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on India – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AstraZeneca Plc
o Exhibit 89: AstraZeneca Plc – Overview
o Exhibit 90: AstraZeneca Plc – Product / Service
o Exhibit 91: AstraZeneca Plc – Key news
o Exhibit 92: AstraZeneca Plc – Key offerings
o 10.4 Bausch Health Companies Inc.
o Exhibit 93: Bausch Health Companies Inc. – Overview
o Exhibit 94: Bausch Health Companies Inc. – Business segments
o Exhibit 95: Bausch Health Companies Inc. – Key news
o Exhibit 96: Bausch Health Companies Inc. – Key offerings
o Exhibit 97: Bausch Health Companies Inc. – Segment focus
o 10.5 Chimerix Inc.
o Exhibit 98: Chimerix Inc. – Overview
o Exhibit 99: Chimerix Inc. – Product / Service
o Exhibit 100: Chimerix Inc. – Key offerings
o 10.6 Exela Pharma Sciences LLC
o Exhibit 101: Exela Pharma Sciences LLC – Overview
o Exhibit 102: Exela Pharma Sciences LLC – Product / Service
o Exhibit 103: Exela Pharma Sciences LLC – Key offerings
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 104: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 105: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 106: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 107: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 108: F. Hoffmann La Roche Ltd. – Segment focus
o 10.8 Fortress Biotech Inc.
o Exhibit 109: Fortress Biotech Inc. – Overview
o Exhibit 110: Fortress Biotech Inc. – Business segments
o Exhibit 111: Fortress Biotech Inc. – Key offerings
o Exhibit 112: Fortress Biotech Inc. – Segment focus
o 10.9 Gilead Sciences Inc.
o Exhibit 113: Gilead Sciences Inc. – Overview
o Exhibit 114: Gilead Sciences Inc. – Product / Service
o Exhibit 115: Gilead Sciences Inc. – Key news
o Exhibit 116: Gilead Sciences Inc. – Key offerings
o 10.10 Merck and Co. Inc.
o Exhibit 117: Merck and Co. Inc. – Overview
o Exhibit 118: Merck and Co. Inc. – Business segments
o Exhibit 119: Merck and Co. Inc. – Key news
o Exhibit 120: Merck and Co. Inc. – Key offerings
o Exhibit 121: Merck and Co. Inc. – Segment focus
o 10.11 Takeda Pharmaceutical Co. Ltd.
o Exhibit 122: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 123: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 124: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 125: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 10.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 126: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 127: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 128: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 129: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 130: Teva Pharmaceutical Industries Ltd. – Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 131: Inclusions checklist
o Exhibit 132: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 133: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 134: Research methodology
o Exhibit 135: Validation techniques employed for market sizing
o Exhibit 136: Information sources
o 11.5 List of abbreviations
o Exhibit 137: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Route of Administration – Market share 2021-2026 (%)
Exhibits25: Data Table on Route of Administration – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Route of Administration
Exhibits27: Data Table on Comparison by Route of Administration
Exhibits28: Chart on Oral – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Oral – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Oral – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Oral – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Parenteral – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Parenteral – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Parenteral – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Parenteral – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others – Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others – Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others – Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Route of Administration ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Denmark – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Denmark – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Denmark – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Denmark – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on India – Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on India – Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on India – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on India – Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AstraZeneca Plc – Overview
Exhibits90: AstraZeneca Plc – Product / Service
Exhibits91: AstraZeneca Plc – Key news
Exhibits92: AstraZeneca Plc – Key offerings
Exhibits93: Bausch Health Companies Inc. – Overview
Exhibits94: Bausch Health Companies Inc. – Business segments
Exhibits95: Bausch Health Companies Inc. – Key news
Exhibits96: Bausch Health Companies Inc. – Key offerings
Exhibits97: Bausch Health Companies Inc. – Segment focus
Exhibits98: Chimerix Inc. – Overview
Exhibits99: Chimerix Inc. – Product / Service
Exhibits100: Chimerix Inc. – Key offerings
Exhibits101: Exela Pharma Sciences LLC – Overview
Exhibits102: Exela Pharma Sciences LLC – Product / Service
Exhibits103: Exela Pharma Sciences LLC – Key offerings
Exhibits104: F. Hoffmann La Roche Ltd. – Overview
Exhibits105: F. Hoffmann La Roche Ltd. – Business segments
Exhibits106: F. Hoffmann La Roche Ltd. – Key news
Exhibits107: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits108: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits109: Fortress Biotech Inc. – Overview
Exhibits110: Fortress Biotech Inc. – Business segments
Exhibits111: Fortress Biotech Inc. – Key offerings
Exhibits112: Fortress Biotech Inc. – Segment focus
Exhibits113: Gilead Sciences Inc. – Overview
Exhibits114: Gilead Sciences Inc. – Product / Service
Exhibits115: Gilead Sciences Inc. – Key news
Exhibits116: Gilead Sciences Inc. – Key offerings
Exhibits117: Merck and Co. Inc. – Overview
Exhibits118: Merck and Co. Inc. – Business segments
Exhibits119: Merck and Co. Inc. – Key news
Exhibits120: Merck and Co. Inc. – Key offerings
Exhibits121: Merck and Co. Inc. – Segment focus
Exhibits122: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits123: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits124: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits125: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits126: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits127: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits128: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits129: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits130: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits131: Inclusions checklist
Exhibits132: Exclusions checklist
Exhibits133: Currency conversion rates for US$
Exhibits134: Research methodology
Exhibits135: Validation techniques employed for market sizing
Exhibits136: Information sources
Exhibits137: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の天然痘治療市場2022年～2026年
  • 世界のアルツハイマー病治療薬市場2022年～2026年
  • 世界の皮膚科用医薬品市場2022年～2026年
  • 世界のシコクビエ市場2022年～2026年
  • 世界のバイオ医薬品分析検査サービス市場2022年～2026年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR73256-22 )"世界のサイトメガロウイルス（CMV）治療薬市場2022年～2026年" (英文：Global Cytomegalovirus (CMV) Therapeutics Market 2022-2026)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。